ebastine has been researched along with Rhinitis, Allergic, Nonseasonal in 14 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ebastine is a second-generation antihistamine which has been shown to be an effective treatment for both seasonal and perennial allergic rhinitis." | 6.44 | Ebastine in allergic rhinitis and chronic idiopathic urticaria. ( Sastre, J, 2008) |
| " No serious adverse events occurred, and study treatments were well tolerated with a low incidence of central nervous system-related adverse events and headache." | 2.69 | A 12-week, placebo-controlled study of the efficacy and safety of ebastine, 10 and 20 mg once daily, in the treatment of perennial allergic rhinitis. Multicentre Study Group. ( Bousquet, J; Gaudaño, EM; Palma Carlos, AG; Staudinger, H, 1999) |
| "Ebastine is a nonsedating and selective histamine H1 receptor antagonist without anticholinergic or sedative effects at therapeutic doses." | 2.69 | Comparative clinical studies with ebastine: efficacy and tolerability. ( Luria, X, 1999) |
| "Ebastine is a new piperidine-containing, relatively nonsedating second-generation H1-receptor antagonist." | 2.67 | Pharmacokinetics and pharmacodynamics of ebastine in children. ( Simons, FE; Simons, KJ; Watson, WT, 1993) |
| "Ebastine treatment produced a significant reduction in the incidence and severity of most symptoms associated with perennial rhinitis." | 2.67 | Ebastine in perennial allergic rhinitis. ( Cadahia García, A; Cano Cantudo, L; Cisteró Bahima, A; Picado Vallés, C; Sanz Amaro, A; Zayas Sanza, JM, 1991) |
| "Ebastine is a second-generation antihistamine which has been shown to be an effective treatment for both seasonal and perennial allergic rhinitis." | 2.44 | Ebastine in allergic rhinitis and chronic idiopathic urticaria. ( Sastre, J, 2008) |
| "Ebastine is a once-daily, non-sedating, selective, long-acting, second-generation antihistamine." | 2.42 | A review of the second-generation antihistamine ebastine for the treatment of allergic disorders. ( De Belder, T; Sys, L; Van Cauwenberge, P, 2004) |
| "Ebastine is a potent second-generation H1-blocker that compares well with others in the class." | 2.40 | Antihistamines in severe/chronic rhinitis. ( Bousquet, J, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (50.00) | 18.2507 |
| 2000's | 6 (42.86) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Braido, F | 1 |
| Sclifò, F | 1 |
| Ferrando, M | 1 |
| Canonica, GW | 1 |
| Izumi, N | 1 |
| Mizuguchi, H | 1 |
| Umehara, H | 1 |
| Ogino, S | 1 |
| Fukui, H | 1 |
| Sastre, J | 1 |
| Van Cauwenberge, P | 1 |
| De Belder, T | 1 |
| Sys, L | 1 |
| Petrovskaia, TIu | 1 |
| Sergeeva, TA | 1 |
| Lopatin, AS | 1 |
| Simons, FE | 1 |
| Watson, WT | 1 |
| Simons, KJ | 1 |
| Benavente, V | 1 |
| Eseverri, JL | 1 |
| Botey, J | 1 |
| Marin, A | 1 |
| Murris-Espin, M | 1 |
| Melac, M | 1 |
| Charpentier, JC | 1 |
| Didier, A | 1 |
| Bousquet, J | 2 |
| Gaudaño, EM | 1 |
| Palma Carlos, AG | 1 |
| Staudinger, H | 1 |
| Luria, X | 1 |
| Picado Vallés, C | 1 |
| Cadahia García, A | 1 |
| Cisteró Bahima, A | 1 |
| Cano Cantudo, L | 1 |
| Sanz Amaro, A | 1 |
| Zayas Sanza, JM | 1 |
4 reviews available for ebastine and Rhinitis, Allergic, Nonseasonal
| Article | Year |
|---|---|
New therapies for allergic rhinitis.
Topics: Administration, Intranasal; Androstadienes; Anti-Allergic Agents; Antibodies, Anti-Idiotypic; Antibo | 2014 |
Ebastine in allergic rhinitis and chronic idiopathic urticaria.
Topics: Animals; Butyrophenones; Chronic Disease; Histamine H1 Antagonists; Humans; Piperidines; Rhinitis, A | 2008 |
A review of the second-generation antihistamine ebastine for the treatment of allergic disorders.
Topics: Anti-Allergic Agents; Asthma; Butyrophenones; Clinical Trials as Topic; Histamine H1 Antagonists, No | 2004 |
Antihistamines in severe/chronic rhinitis.
Topics: Butyrophenones; Histamine H1 Antagonists; Humans; Piperidines; Rhinitis, Allergic, Perennial; Rhinit | 1998 |
6 trials available for ebastine and Rhinitis, Allergic, Nonseasonal
| Article | Year |
|---|---|
Pharmacokinetics and pharmacodynamics of ebastine in children.
Topics: Butyrophenones; Child; Double-Blind Method; Drug Administration Schedule; Female; Histamine H1 Antag | 1993 |
[Ebastine : treatment of perennial rhinitis in the child].
Topics: Adolescent; Butyrophenones; Carbachol; Child; Conjunctivitis, Allergic; Female; Histamine H1 Antagon | 1996 |
Comparison of efficacy and safety of cetirizine and ebastine in patients with perennial allergic rhinitis.
Topics: Adolescent; Adult; Aged; Butyrophenones; Cetirizine; Double-Blind Method; Female; Histamine H1 Antag | 1998 |
A 12-week, placebo-controlled study of the efficacy and safety of ebastine, 10 and 20 mg once daily, in the treatment of perennial allergic rhinitis. Multicentre Study Group.
Topics: Adolescent; Adult; Butyrophenones; Child; Double-Blind Method; Female; Histamine H1 Antagonists; Hum | 1999 |
Comparative clinical studies with ebastine: efficacy and tolerability.
Topics: Adolescent; Adult; Aged; Butyrophenones; Child; Double-Blind Method; Electrocardiography; Electrocar | 1999 |
Ebastine in perennial allergic rhinitis.
Topics: Adult; Butyrophenones; Double-Blind Method; Female; Histamine H1 Antagonists; Humans; Male; Piperidi | 1991 |
4 other studies available for ebastine and Rhinitis, Allergic, Nonseasonal
| Article | Year |
|---|---|
Analysis of disease-dependent sedative profiles of H(1)-antihistamines by large-scale surveillance using the visual analog scale.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Asthma; Butyrophenones; Cetirizine; Child; Chlorpheniram | 2008 |
[In seasonal and perennial rhinitis. Superiority to standard H1 blockers].
Topics: Anti-Allergic Agents; Butyrophenones; Cetirizine; Double-Blind Method; Histamine H1 Antagonists; His | 2003 |
[Antihistaminics. Side effects also after raising dosage at the placebo level].
Topics: Anti-Allergic Agents; Benzimidazoles; Butyrophenones; Cetirizine; Double-Blind Method; Histamine H1 | 2003 |
[Ebastine (kestine 20) in therapy of allergic rhinitis].
Topics: Adult; Butyrophenones; Female; Histamine H1 Antagonists; Humans; Male; Piperidines; Rhinitis, Allerg | 2007 |